Search results
3 cze 2022 · Because of the high risk of developing severe COVID-19, patients with cancer have been prioritized for access to available vaccines in jurisdictions around the globe. 67 However, because of disease-associated and therapy-induced impairment of the immune system, many of these patients are more likely to develop a less efficient immune response ...
11 mar 2022 · In this Review, the authors provide an overview of the efficacy and immunogenicity of COVID-19 vaccines in patients with cancer, and discuss alternatives to vaccination for those...
In the SOAP-02 study, the authors analysed the safety and efficacy of the BNT162b2 vaccine in 151 patients with cancer (95 with solid cancer and 56 with haematological cancer), as well as in a non-age-matched group of 54 healthy controls, and aimed to understand the impact of the first dose in patients with cancer after 3 weeks. 4 The cancer ...
30 cze 2023 · In fact, the COVID-19 vaccine has been shown to be safe and effective in patients treated with ICIs. In this review, we report the vital clinical observations of SARS-CoV-2 infection or...
9 lis 2021 · Most patients with cancer develop, while receiving chemotherapy, immunotherapy, or both for a solid tumour, an adequate antibody response to vaccination with the mRNA-1273 COVID-19 vaccine. The vaccine is also safe in these patients.
6 wrz 2022 · Thus, cancer patients are more susceptible to develop COVID-19 infection. As COVID-19 vaccines became available, patients with cancer would benefit from receiving the vaccine. This article aims to review the recent evidences and recommendations about COVID-19 vaccination in cancer patients.
Introduction. After an outbreak of a novel coronavirus was first detected in Wuhan, China in December 2019 [], World Health Organization declared severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to be the cause of coronavirus disease 2019 (COVID-19) in March 2020.Throughout the COVID-19 pandemic, we have learned that immunosuppression is a well-known risk factor for severe SARS-CoV ...
